1. Home
  2. Labeler Index
  3. Kyowa Kirin, Inc.
  4. NDC Product Code: 42747-726 Sancuso

NDC 42747-726 Sancuso

Granisetron Patch Transdermal - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 42747-726?
  4. Sancuso Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. NDC to RxNorm Crosswalk
  8. Pharmacologic Classes
  9. Patient Education

Product Information

NDC Product Code:
42747-726
Proprietary Name:
Sancuso
Non-Proprietary Name: [1]
Granisetron
Substance Name: [2]
Granisetron
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Patch - A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms ‘extended release film’ and ‘system’.
Administration Route(s): [4]
  • Transdermal - Administration through the dermal layer of the skin to the systemic circulation by diffusion.
    • Labeler Name: [5]
    Kyowa Kirin, Inc.
    Labeler Code:
    42747
    Product Label ID:
    ba44e7d8-0c71-4eb9-a951-3d91038293c5
    FDA Application Number: [6]
    NDA022198
    Marketing Category: [8]
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date: [9]
    09-12-2008
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Structure:
    Code Navigator:

    Product Packages

    NDC Code 42747-726-01

    Package Description: 1 POUCH in 1 CARTON / 1 PATCH in 1 POUCH / 168 h in 1 PATCH

    Price per Unit: $633.34006 per EA

    NDC Code 42747-726-72

    Package Description: 1 POUCH in 1 CARTON / 1 PATCH in 1 POUCH / 168 h in 1 PATCH

    Product Details

    What is NDC 42747-726?

    The NDC code 42747-726 is assigned by the FDA to the product Sancuso which is a human prescription drug product labeled by Kyowa Kirin, Inc.. The generic name of Sancuso is granisetron. The product's dosage form is patch and is administered via transdermal form. The product is distributed in 2 packages with assigned NDC codes 42747-726-01 1 pouch in 1 carton / 1 patch in 1 pouch / 168 h in 1 patch, 42747-726-72 1 pouch in 1 carton / 1 patch in 1 pouch / 168 h in 1 patch. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Sancuso?

    This medication is used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). It works by blocking one of the body's natural substances (serotonin) that can cause vomiting.

    What are Sancuso Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
    • GRANISETRON 3.1 mg/24h - A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients.

    Which are Sancuso UNII Codes?

    The UNII codes for the active ingredients in this product are:

    What is the NDC to RxNorm Crosswalk for Sancuso?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
    • RxCUI: 825003 - granisetron 3.1 MG/Day 7 Day Transdermal System
    • RxCUI: 825003 - 168 HR granisetron 0.129 MG/HR Transdermal System
    • RxCUI: 825003 - granisetron 3.1 MG/Day Weekly Transdermal Patch
    • RxCUI: 825005 - Sancuso 3.1 MG/Day 7 Day Transdermal System
    • RxCUI: 825005 - 168 HR granisetron 0.129 MG/HR Transdermal System [Sancuso]

    Which are the Pharmacologic Classes for Sancuso?

    A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

    * Please review the disclaimer below.

    Patient Education

    Granisetron Transdermal Patch


    Granisetron transdermal patches are used to prevent nausea and vomiting caused by chemotherapy. Granisetron is in a class of medications called 5HT3 inhibitors. It works by blocking serotonin, a natural substance in the body that causes nausea and vomiting.
    [Learn More]


    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".